MetLife Investment Management’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,462	Closed	-$16.2K	–	2790
2021 Q4	$16.2K	Sell	6,462 -26,366	-80%	-$104K	﹤0.01%	2488
2021 Q3	$168K	Buy	32,828 +9,327	+40%	+$56.6K	﹤0.01%	2194
2021 Q2	$195K	Sell	23,501 -12,347	-34%	-$104K	﹤0.01%	2188
2021 Q1	$312K	Buy	35,848 +4,350	+14%	+$45K	﹤0.01%	1792
2020 Q4	$342K	Sell	31,498 -8,472	-21%	-$105K	﹤0.01%	1684
2020 Q3	$477K	Sell	39,970 -9,258	-19%	-$124K	0.01%	1390
2020 Q2	$791K	Buy	49,228 +16,843	+52%	+$294K	0.01%	1124
2020 Q1	$502K	Sell	32,385 -3,837	-11%	-$82.4K	0.01%	1214
2019 Q4	$891K	Hold	36,222	–	–	0.01%	1150
2019 Q3	$374K	Sell	36,222 -10,574	-23%	-$133K	﹤0.01%	1571
2019 Q2	$587K	Buy	46,796 +21,721	+87%	+$279K	0.01%	1382
2019 Q1	$311K	Hold	25,075	–	–	﹤0.01%	1733
2018 Q4	$154K	Hold	25,075	–	–	﹤0.01%	2056
2018 Q3	$266K	Hold	25,075	–	–	﹤0.01%	1928
2018 Q2	$340K	Buy	25,075 +4,155	+20%	+$64.7K	﹤0.01%	1645
2018 Q1	$371K	Hold	20,920	–	–	﹤0.01%	1556
2017 Q4	$263K	Buy	+20,920	New	+$304K	﹤0.01%	1774